Are you ready to begin care at the Drake Institute?
Get Started >>
Do you need more information before you begin?
Ask Us >>
News Videos - Drake Institute is the News
View Videos>>
Audio FAQ - Learn about ADD from Dr. Velkoff, MD
Learn
More >>
Listen to Radio Interviews with Dr. David Velkoff, MD
Listen
Now >>
|
ADD / ADHD Treatment 
Treatment of Attention Deficit Disorder
/ Attention Deficit Hyperactivity Disorder, Language Disorders and Autistic
Spectrum Disorders
Prior to treatment at the Drake Institute, many of
our patients suffered from some of the following symptoms. Please review
these behaviors and mark those that apply to your child or adult family
member. The checklist you receive should be brought to the orientation
seminar so one of our clinical staff can determine if your child may be a candidate
for our help.
-
There is a major difference in how well
they can sustain focus on interesting activities (Entertainment,
Games, Legos, Video, TV) versus routine, mundane, or academic tasks.
-
Inability to get homework done without
frequent monitoring by a parent
-
Difficulty in paying attention or staying
on task
-
Being easily distracted and rarely finishing
one project before going to the next
-
A weak or nonexistent sense of time or
planning; poor time management
Proven
Treatment
The clinical effectiveness of EEG biofeedback (neurofeedback) in the
treatment of ADD or ADHD has been evident for 2 decades. There is extensive
scientific research for many years supporting the clinical effectiveness
of neurofeedback. As a medical facility, with the options of choosing
drug therapy, our years of scientific and clinical knowldege leads us
to choose EEG neurofeedback over the other choices for the treatment
of ADHD. For maximum clinical results, psychosocial, family and
educational support should be integrated with the EEG neurofeedback
for comprehensive care. Neurofeedback is not a stand alone treatment
but it is an essential component of our successful Full Care program.
Drake’s
Neurophysical Training Program - N.P.T.
The Neurophysical Training Program reflects what has
been learned after 25 years and 9000 patients. Unlike programs based
on temporarily regulating brain patterns that are needed for required
levels of attention, we are looking for long term change without ongoing
treatment. Drug therapy is clearly temporary symptom relief. What may
be less obvious is that some other treatments that appear to be similar
to ours can often be temporary as well.
We seek long term change in
the brain’s capacity, without side effects. To accomplish this
we have our N.P.T. program which includes all the necessary factors
required to meet this goal in the least amount of treatment time possible,
with the best results. This is possible because of the details you will
find below that are included in our tailor made program, based on all
of our successes and limited failures.
Read
more about our Training Program
Following
are some landmark scientific studies on the effectiveness of neurofeedback
in treating ADD.
Are the
drugs for ADD / ADHD Safe?
Physicians
must always weigh risks versus benefits. Though we feel that there are
patients who may require stimulant drugs, it is a much smaller percent
of patients than are currently put on stimulant drugs. Short-term, the
drugs can cause anorexia, tics, psychotic reactions, altered cardiovascular
functioning, emotional rebound, withdrawal effects, a slowed growth
rate and chromosome damage. The long-term negative consequences of these
drugs in childhood or adolescences are poorly studied, so remains largely
unknown. There is concern with the possibilities of increased vulnerabilities
to later addictions and other health problems. For these reasons,
we feel that drugs should be the last option, not the first.
Following
are significant scientific studies on the risks of these drugs, particularly
in children.
Study:
Case
Report: Methylphenidate-Related Growth Impairment
Authors: Kristian
Holtkamp, M.D., Birgitta Peters-Wallraf, Stefan Wuller, Roland
Pfaaffle,M.D., and Beate Herpertz-Dahlmann,M.D.,
Journal Publication: Journal
of Child & Adolescent Psychopharmacology, Vol. 12, No. 1,
2002, Copyright Mary An Liebert, Inc. Pp 55-61
|
Study: Methlyphenidate
Increases Heart Rate, Blood Pressure and Plasma Epinephrine in Normal
Subjects
Authors: P.R. Joice,
M.G. Nicholls, and R.A. Donald
Journal Publication: Life
Sciences, Vol. 34, No. 18, 1984, pp 1701 - 1711, Pergamon Press |
Study: Psychotic
Side Effects of Psychostimulants: A 5-Year Review
Authors: Esther
Cherland, M.D, FRCPC, Renee Fitzpatrick, MB, MRCPsych, FRCPC,
Journal Publication: Canadian
Journal of Psychiatry, Vol. 44, October 1999. |
Study: Prospective
Study of Tobacco Smoking and Substance Dependencies among Samples
of ADHD and Non-ADHD Participants
Authors: Nadine
M. Lambert and Carolyn S. Hartsough
Journal Publication: Journal
of Learning Disabilities, Vol. 31, No. 6, November /December 1998,
Pp 553-554 |
What
is Brain Mapping?
Quantitative EEG brainmapping (QEEG) or quantitative
electroencephalogram is a cutting edge diagnostic procedure that can
actually pinpoint the abnormal brainwaves in ADD patients.
By itself, the QEEG does
not diagnose ADD, but carefully correlating the QEEG information with
other clinical findings, it can support the diagnosis of ADHD or suggest
otherwise.

Because
of different subtypes of ADD, we feel that a QEEG is important in complex
cases or patients with comorbidities such as anxiety, depression, high
functioning autism, obsessive-compulsive disorder, tics, overly aggressive
or explosive behavior, and oppositional-defiant disorder. The QEEG can
identify the specific pattern of the brainwave abnormality and help
in developing the most effective neurofeedback protocols for the
patient. It is similar to doing a bacterial culture and determining
which antibiotic would work best for that infection. We do not feel
that every patient requires a brainmapping but more complex cases do.
Following are scientific studies on QEEG Brainmapping
and ADD/ADHD.
|
Study: EEG
evidence for a new conceptualisation of attention deficit hyperactivity
diorder
Authors: Adam R.
Clarke, Robert J. Barry, Rory McCarthy, Mark Selikowitz, and Christopher
R. Brown
Journal Publication: Clinical
Neurophysiology 113 (2002) 1036 - 1044 |
Study:
Simultaneous
EEG and EDA measures in adolescent attention deficit hyperactivity
disorder
Authors: I. Lazzaro,
E. Gordon, C.L. Lim, M. Plahn, S. Whitmont, S. Clarke, R.J. Barry,
A. Dosen, R. Meares
Journal Publication: International
Journal of Psychophysiology 34 (1999) 123 - 134 |
Study: Excess
beta activity in children with attention-deficit/hyperactivity disorder:
an atypical electrophysiological group
Authors: Adam R.
Clarke, Robert J. Barry, Rory McCarthy, Mark Selikowitz
Journal Publication: Psychiatry
Research 103 (2001) 205 - 218 |
Treatment of Attention
Deficit Disorder and Attention Deficit Hyperactivity Disorders for Children
and Adults
Learn more about the Drake Institute's
treatment for ADD / ADHD
Neurofeedback, Drugs, Treatments
& Related Information
|
 |